Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line

Anticancer Res. 2013 Oct;33(10):4319-24.

Abstract

Background/aim: The present study investigated the effect of eicosapentaenoic acid (EPA) on nuclear factor-kappa B (NF-κB) activation, inflammatory interleukin-6 (IL-6) production, and cell proliferation in a human oesophageal carcinoma cell line (TE-1).

Materials and methods: Lipopolysaccharide (LPS)-induced IL-6 production in TE-1 cells in the presence or absence of EPA was determined using enzyme-linked immunosorbent assay (ELISA). The proliferation of TE-1 cells was determined by the WST-1 assay. TE-1 cells were stained with Hoechst 33342 and propidium iodide to observe apoptosis. Immunohistochemical staining of NF-κB in TE-1 cells was performed.

Results: LPS increased IL-6 production in TE-1 cells, and EPA treatment prevented this effect. EPA treatment inhibited NF-κB activation and induced apoptosis of TE-1 cells.

Conclusion: EPA inhibits NF-κB activation and IL-6 production in oesophageal cancer cells, their inducing apoptosis. These effects of EPA may be of benefit in improving the outcome of cancer surgery.

Keywords: Esophageal cancer; NF-κB; TE-1 cells; apoptosis; cytokines; eicosapentaenoic acid.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology*
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Cell Proliferation / drug effects*
  • Cell Shape / drug effects
  • Eicosapentaenoic Acid / pharmacology*
  • Esophageal Neoplasms
  • Humans
  • Interleukin-6 / metabolism*
  • Lipopolysaccharides / pharmacology
  • NF-kappa B / metabolism
  • Protein Transport

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • IL6 protein, human
  • Interleukin-6
  • Lipopolysaccharides
  • NF-kappa B
  • Eicosapentaenoic Acid